Provation partners with ACL Laboratories for pathologic partnership
At a Glance
Provation, a software and SaaS provider of procedural documentation and clinical decision support tools, has teamed with ACL Laboratories. This new partnership joins a growing list of renowned pathology companies that have integrated Provation technologies.
Provation, a provider of software and SaaS of procedure documentation and clinical decision support solutions, announced its partnership with ACL Laboratories for pathologic interaction with Provation MD and Provation Apex cloud-based procedure documentation solutions.
Provation gives providers the tools they need to provide high-quality care to everyone. Provation’s broad portfolio includes physician and nursing documentation solutions that span the whole patient experience, from pre-procedure to post-procedure.
Provation is thrilled to have ACL Laboratories as an official pathology partner. Together, ACL and Provation can enhance and automate the digital exchange of patient data for our mutual customers, while empowering clinicians with the information needed to make vital diagnostic decisions and care plans.Brandon Hoheisel, director of Strategic Partnerships at Provation
The Centers for Medicare & Medicaid Services (CMS) mandates that providers preserve more accurate, up-to-date patient medical records. Providing pathology integration facilitates communication between doctors and pathology labs like ACL Laboratories. This new collaboration joins a growing list of leading pathology providers who have engaged in Provation solutions integration.
ACL Laboratories is one of the biggest networks of dedicated pathologists in the United States, offering a full spectrum of anatomic and clinical pathology services in Illinois, Wisconsin, and Northern Indiana.
The COVID-19 pandemic has drastically accelerated the demand for telemedicine and real-time data transfers, including the digital exchange and immediate processing of pathology test results. While this pathology integration focuses on colon and esophageal cancer detection and not COVID-19, this partnership came at an unprecedented time in healthcare that will help ACL meet the growing need for secure electronic pathology communication.Kevin Anders, director of Sales at ACL Laboratories